HEADER TRANSFERASE 28-JUN-11 3ZSG
TITLE X-RAY STRUCTURE OF P38ALPHA BOUND TO TAK-715
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: MAP KINASE 14, MAPK 14, CYTOKINE SUPPRESSIVE ANTI-
COMPND 5 INFLAMMATORY DRUG-BINDING PROTEIN, CSAID-BINDING PROTEIN, CSBP, MAP
COMPND 6 KINASE MXI2, MAX-INTERACTING PROTEIN 2, MITOGEN-ACTIVATED PROTEIN
COMPND 7 KINASE P38 ALPHA, MAP KINASE P38 ALPHA, SAPK2A, P38A;
COMPND 8 EC: 2.7.11.24;
COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMAL-C2X LIKE
KEYWDS TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR R.AZEVEDO,M.VAN ZEELAND,H.RAAIJMAKERS,B.KAZEMIER,A.OUBRIE
REVDAT 6 08-MAY-24 3ZSG 1 HETSYN
REVDAT 5 29-JUL-20 3ZSG 1 COMPND REMARK HETNAM SITE
REVDAT 4 07-FEB-18 3ZSG 1 JRNL
REVDAT 3 15-AUG-12 3ZSG 1 JRNL
REVDAT 2 25-JUL-12 3ZSG 1 JRNL
REVDAT 1 13-JUN-12 3ZSG 0
JRNL AUTH R.AZEVEDO,M.VAN ZEELAND,H.RAAIJMAKERS,B.KAZEMIER,J.DE VLIEG,
JRNL AUTH 2 A.OUBRIE
JRNL TITL X-RAY STRUCTURE OF P38 ALPHA BOUND TO TAK-715: COMPARISON
JRNL TITL 2 WITH THREE CLASSIC INHIBITORS.
JRNL REF ACTA CRYSTALLOGR. D BIOL. V. 68 1041 2012
JRNL REF 2 CRYSTALLOGR.
JRNL REFN ESSN 1399-0047
JRNL PMID 22868770
JRNL DOI 10.1107/S090744491201997X
REMARK 2
REMARK 2 RESOLUTION. 1.89 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.5.0102
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.08
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 3 NUMBER OF REFLECTIONS : 27922
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.191
REMARK 3 R VALUE (WORKING SET) : 0.189
REMARK 3 FREE R VALUE : 0.233
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1472
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.89
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.94
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2048
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0
REMARK 3 BIN R VALUE (WORKING SET) : 0.2250
REMARK 3 BIN FREE R VALUE SET COUNT : 92
REMARK 3 BIN FREE R VALUE : 0.3030
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2721
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 49
REMARK 3 SOLVENT ATOMS : 316
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.74
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.01000
REMARK 3 B22 (A**2) : -0.01000
REMARK 3 B33 (A**2) : 0.00000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.165
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.150
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.098
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.575
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2898 ; 0.009 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): 1972 ; 0.001 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3949 ; 1.211 ; 1.980
REMARK 3 BOND ANGLES OTHERS (DEGREES): 4818 ; 0.845 ; 3.000
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 353 ; 5.559 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;33.241 ;23.971
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 499 ;13.527 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;14.561 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 441 ; 0.075 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3179 ; 0.005 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 588 ; 0.001 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1716 ; 0.618 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 680 ; 0.120 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2796 ; 1.144 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1182 ; 1.551 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1140 ; 2.579 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 3
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 5
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 4 A 28
REMARK 3 RESIDUE RANGE : A 40 A 166
REMARK 3 RESIDUE RANGE : A 185 A 240
REMARK 3 RESIDUE RANGE : A 266 A 321
REMARK 3 RESIDUE RANGE : A 1353 A 1353
REMARK 3 ORIGIN FOR THE GROUP (A): 11.9140 31.6330 16.8790
REMARK 3 T TENSOR
REMARK 3 T11: 0.0648 T22: 0.0077
REMARK 3 T33: 0.0245 T12: -0.0131
REMARK 3 T13: -0.0060 T23: 0.0086
REMARK 3 L TENSOR
REMARK 3 L11: 1.3472 L22: 0.5827
REMARK 3 L33: 0.5803 L12: -0.1744
REMARK 3 L13: -0.0275 L23: 0.0103
REMARK 3 S TENSOR
REMARK 3 S11: 0.0362 S12: 0.0094 S13: 0.1036
REMARK 3 S21: 0.0002 S22: -0.0276 S23: -0.0404
REMARK 3 S31: -0.0784 S32: 0.0403 S33: -0.0087
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 241 A 265
REMARK 3 ORIGIN FOR THE GROUP (A): -13.0330 30.3140 36.9180
REMARK 3 T TENSOR
REMARK 3 T11: 0.0665 T22: 0.1687
REMARK 3 T33: 0.1604 T12: -0.0351
REMARK 3 T13: 0.0532 T23: 0.0007
REMARK 3 L TENSOR
REMARK 3 L11: 3.0198 L22: 7.8468
REMARK 3 L33: 6.3469 L12: -1.3942
REMARK 3 L13: 1.9717 L23: -1.2517
REMARK 3 S TENSOR
REMARK 3 S11: -0.0123 S12: -0.3255 S13: 0.3661
REMARK 3 S21: 0.1456 S22: 0.0873 S23: 0.2168
REMARK 3 S31: -0.1977 S32: -0.6648 S33: -0.0750
REMARK 3
REMARK 3 TLS GROUP : 3
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 322 A 347
REMARK 3 ORIGIN FOR THE GROUP (A): 25.7580 17.1790 28.6900
REMARK 3 T TENSOR
REMARK 3 T11: 0.0339 T22: 0.0355
REMARK 3 T33: 0.0690 T12: 0.0027
REMARK 3 T13: -0.0079 T23: 0.0390
REMARK 3 L TENSOR
REMARK 3 L11: 2.0078 L22: 1.4871
REMARK 3 L33: 5.6992 L12: -0.1920
REMARK 3 L13: 1.7205 L23: -0.3439
REMARK 3 S TENSOR
REMARK 3 S11: 0.0388 S12: -0.1505 S13: -0.0261
REMARK 3 S21: 0.0380 S22: -0.0085 S23: 0.0003
REMARK 3 S31: 0.1387 S32: -0.0470 S33: -0.0302
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : BABINET MODEL WITH MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS.
REMARK 4
REMARK 4 3ZSG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUN-11.
REMARK 100 THE DEPOSITION ID IS D_1290048840.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-SEP-10
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU-MSC R-AXIS IV
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29397
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890
REMARK 200 RESOLUTION RANGE LOW (A) : 41.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 6.200
REMARK 200 R MERGE (I) : 0.06000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.7000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 100.0
REMARK 200 R MERGE FOR SHELL (I) : 0.45000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.700
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: REFMAC
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NONE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.22
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.5
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.27000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.38000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.08500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.38000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.27000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.08500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -1
REMARK 465 SER A 0
REMARK 465 HIS A 1
REMARK 465 SER A 2
REMARK 465 GLN A 3
REMARK 465 ALA A 172
REMARK 465 ARG A 173
REMARK 465 HIS A 174
REMARK 465 THR A 175
REMARK 465 ASP A 176
REMARK 465 ASP A 177
REMARK 465 GLU A 178
REMARK 465 MET A 179
REMARK 465 THR A 180
REMARK 465 GLY A 181
REMARK 465 TYR A 182
REMARK 465 VAL A 183
REMARK 465 LEU A 353
REMARK 465 ASP A 354
REMARK 465 GLN A 355
REMARK 465 GLU A 356
REMARK 465 GLU A 357
REMARK 465 MET A 358
REMARK 465 GLU A 359
REMARK 465 SER A 360
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH A 2089 O HOH A 2090 0.97
REMARK 500 O HOH A 2276 O HOH A 2277 1.08
REMARK 500 O HOH A 2177 O HOH A 2178 1.09
REMARK 500 O HOH A 2141 O HOH A 2142 1.30
REMARK 500 O HOH A 2003 O HOH A 2004 1.44
REMARK 500 O HOH A 2058 O HOH A 2065 2.02
REMARK 500 O HOH A 2289 O HOH A 2290 2.02
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O HOH A 2222 O HOH A 2290 4456 2.07
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 14 46.80 39.67
REMARK 500 ASN A 100 -30.62 -139.46
REMARK 500 ARG A 149 -11.55 82.35
REMARK 500 ASP A 150 47.08 -152.34
REMARK 500 CYS A 162 42.82 37.51
REMARK 500 MET A 198 -166.52 53.16
REMARK 500 MET A 198 -177.47 63.71
REMARK 500 ASP A 227 -168.04 -163.02
REMARK 500
REMARK 500 REMARK: NULL
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2BAJ RELATED DB: PDB
REMARK 900 P38ALPHA BOUND TO PYRAZOLOUREA
REMARK 900 RELATED ID: 1WFC RELATED DB: PDB
REMARK 900 STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATEDPROTEIN
REMARK 900 KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUEOF THE YEAST
REMARK 900 HOG1 PROTEIN
REMARK 900 RELATED ID: 1W7H RELATED DB: PDB
REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE
REMARK 900 INHIBITOR
REMARK 900 RELATED ID: 1WBO RELATED DB: PDB
REMARK 900 FRAGMENT BASED P38 INHIBITORS
REMARK 900 RELATED ID: 1KV2 RELATED DB: PDB
REMARK 900 HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796
REMARK 900 RELATED ID: 1BMK RELATED DB: PDB
REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655
REMARK 900 RELATED ID: 1YQJ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A
REMARK 900 SELECTIVEPYRIDAZINE INHIBITOR
REMARK 900 RELATED ID: 1BL7 RELATED DB: PDB
REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025
REMARK 900 RELATED ID: 1ZYJ RELATED DB: PDB
REMARK 900 HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A
REMARK 900 RELATED ID: 1A9U RELATED DB: PDB
REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580
REMARK 900 RELATED ID: 1WBT RELATED DB: PDB
REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING
REMARK 900 FRAGMENT-BASED LEAD GENERATION.
REMARK 900 RELATED ID: 2I0H RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38ALPHA IN COMPLEX WITH ANARYLPYRIDAZINONE
REMARK 900 RELATED ID: 3ZS5 RELATED DB: PDB
REMARK 900 STRUCTURAL BASIS FOR KINASE SELECTIVITY OF THREE CLINICAL P38ALPHA
REMARK 900 INHIBITORS
REMARK 900 RELATED ID: 2YIW RELATED DB: PDB
REMARK 900 TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE
REMARK 900 RELATED ID: 2BAQ RELATED DB: PDB
REMARK 900 P38ALPHA BOUND TO RO3201195
REMARK 900 RELATED ID: 1WBV RELATED DB: PDB
REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING
REMARK 900 FRAGMENT-BASED LEAD GENERATION.
REMARK 900 RELATED ID: 1ZZ2 RELATED DB: PDB
REMARK 900 TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING ACOMMON
REMARK 900 DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDINGMODES
REMARK 900 RELATED ID: 1DI9 RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE INCOMPLEX
REMARK 900 WITH 4-[3-METHYLSULFANYLANILINO]-6,7- DIMETHOXYQUINAZOLINE
REMARK 900 RELATED ID: 1W83 RELATED DB: PDB
REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE
REMARK 900 INHIBITOR
REMARK 900 RELATED ID: 1BL6 RELATED DB: PDB
REMARK 900 THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995
REMARK 900 RELATED ID: 1M7Q RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH
REMARK 900 ADIHYDROQUINAZOLINONE INHIBITOR
REMARK 900 RELATED ID: 1IAN RELATED DB: PDB
REMARK 900 HUMAN P38 MAP KINASE INHIBITOR COMPLEX
REMARK 900 RELATED ID: 1OZ1 RELATED DB: PDB
REMARK 900 P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4- AZAINDOLEINHIBITOR
REMARK 900 RELATED ID: 1WBN RELATED DB: PDB
REMARK 900 FRAGMENT BASED P38 INHIBITORS
REMARK 900 RELATED ID: 2BAK RELATED DB: PDB
REMARK 900 P38ALPHA MAP KINASE BOUND TO MPAQ
REMARK 900 RELATED ID: 2BAL RELATED DB: PDB
REMARK 900 P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE
REMARK 900 RELATED ID: 1WBS RELATED DB: PDB
REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING
REMARK 900 FRAGMENT-BASED LEAD GENERATION.
REMARK 900 RELATED ID: 1OUY RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO-
REMARK 900 PYRIMIDINE INHIBITOR
REMARK 900 RELATED ID: 1OUK RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH APYRIDINYLIMIDAZOLE
REMARK 900 INHIBITOR
REMARK 900 RELATED ID: 2Y8O RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A MAPK DOCKING
REMARK 900 PEPTIDE
REMARK 900 RELATED ID: 2YIS RELATED DB: PDB
REMARK 900 TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE.
REMARK 900 RELATED ID: 1R39 RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38ALPHA
REMARK 900 RELATED ID: 1KV1 RELATED DB: PDB
REMARK 900 P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1
REMARK 900 RELATED ID: 1WBW RELATED DB: PDB
REMARK 900 IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING
REMARK 900 FRAGMENT-BASED LEAD GENERATION.
REMARK 900 RELATED ID: 1W82 RELATED DB: PDB
REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE
REMARK 900 INHIBITOR
REMARK 900 RELATED ID: 2YIX RELATED DB: PDB
REMARK 900 TRIAZOLOPYRIDINE INHIBITORS OF P38
REMARK 900 RELATED ID: 1R3C RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38ALPHA C162S MUTANT
REMARK 900 RELATED ID: 1OVE RELATED DB: PDB
REMARK 900 THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH ADIHYDROQUINOLINONE
REMARK 900 RELATED ID: 1ZZL RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE
REMARK 900 RELATED ID: 1W84 RELATED DB: PDB
REMARK 900 P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE
REMARK 900 INHIBITOR
REMARK 900 RELATED ID: 3ZSH RELATED DB: PDB
REMARK 900 X-RAY STRUCTURE OF P38ALPHA BOUND TO SCIO-469
REMARK 900 RELATED ID: 3ZSI RELATED DB: PDB
REMARK 900 X-RAY STRUCTURE OF P38ALPHA BOUND TO VX-745
DBREF 3ZSG A 2 360 UNP Q16539 MK14_HUMAN 2 360
SEQADV 3ZSG GLY A -1 UNP Q16539 EXPRESSION TAG
SEQADV 3ZSG SER A 0 UNP Q16539 EXPRESSION TAG
SEQADV 3ZSG HIS A 1 UNP Q16539 EXPRESSION TAG
SEQRES 1 A 362 GLY SER HIS SER GLN GLU ARG PRO THR PHE TYR ARG GLN
SEQRES 2 A 362 GLU LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR
SEQRES 3 A 362 GLN ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER
SEQRES 4 A 362 VAL CYS ALA ALA PHE ASP THR LYS THR GLY LEU ARG VAL
SEQRES 5 A 362 ALA VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE
SEQRES 6 A 362 HIS ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS
SEQRES 7 A 362 HIS MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL
SEQRES 8 A 362 PHE THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL
SEQRES 9 A 362 TYR LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN
SEQRES 10 A 362 ILE VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN
SEQRES 11 A 362 PHE LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE
SEQRES 12 A 362 HIS SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER
SEQRES 13 A 362 ASN LEU ALA VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU
SEQRES 14 A 362 ASP PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR
SEQRES 15 A 362 GLY TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE
SEQRES 16 A 362 MET LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE
SEQRES 17 A 362 TRP SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY
SEQRES 18 A 362 ARG THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU
SEQRES 19 A 362 LYS LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU
SEQRES 20 A 362 LEU LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR
SEQRES 21 A 362 ILE GLN SER LEU THR GLN MET PRO LYS MET ASN PHE ALA
SEQRES 22 A 362 ASN VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU
SEQRES 23 A 362 LEU GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE
SEQRES 24 A 362 THR ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN
SEQRES 25 A 362 TYR HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR
SEQRES 26 A 362 ASP GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU
SEQRES 27 A 362 TRP LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL
SEQRES 28 A 362 PRO PRO PRO LEU ASP GLN GLU GLU MET GLU SER
HET T75 A 400 29
HET BOG A1353 20
HETNAM T75 TAK-715
HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE
HETSYN T75 N-{4-[2-ETHYL-4-(3-METHYLPHENYL)-1,3-THIAZOL-5-
HETSYN 2 T75 YL]PYRIDIN-2-YL}BENZAMIDE
HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D-
HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE
FORMUL 2 T75 C24 H21 N3 O S
FORMUL 3 BOG C14 H28 O6
FORMUL 4 HOH *316(H2 O)
HELIX 1 1 SER A 61 MET A 78 1 18
HELIX 2 2 SER A 95 PHE A 99 5 5
HELIX 3 3 ASP A 112 LYS A 118 1 7
HELIX 4 4 THR A 123 ALA A 144 1 22
HELIX 5 5 LYS A 152 SER A 154 5 3
HELIX 6 6 ALA A 190 LEU A 195 1 6
HELIX 7 7 THR A 203 GLY A 219 1 17
HELIX 8 8 ASP A 227 GLY A 240 1 14
HELIX 9 9 GLY A 243 LYS A 248 1 6
HELIX 10 10 SER A 252 SER A 261 1 10
HELIX 11 11 ASN A 269 PHE A 274 1 6
HELIX 12 12 ASN A 278 LEU A 289 1 12
HELIX 13 13 ASP A 292 ARG A 296 5 5
HELIX 14 14 THR A 298 ALA A 304 1 7
HELIX 15 15 HIS A 305 ALA A 309 5 5
HELIX 16 16 GLN A 325 ARG A 330 5 6
HELIX 17 17 LEU A 333 SER A 347 1 15
SHEET 1 AA 2 PHE A 8 LEU A 13 0
SHEET 2 AA 2 THR A 16 PRO A 21 -1 O THR A 16 N LEU A 13
SHEET 1 AB 5 TYR A 24 GLY A 33 0
SHEET 2 AB 5 GLY A 36 ASP A 43 -1 O GLY A 36 N GLY A 33
SHEET 3 AB 5 LEU A 48 LEU A 55 -1 O LEU A 48 N ASP A 43
SHEET 4 AB 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53
SHEET 5 AB 5 ASP A 88 PHE A 90 -1 O ASP A 88 N VAL A 105
SHEET 1 AC 2 LEU A 156 VAL A 158 0
SHEET 2 AC 2 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157
CRYST1 68.540 70.170 74.760 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014590 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014251 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013376 0.00000